Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1713889

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	National Learning Disability Board
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when the National Learning Disability Board last met.
	tabling member constituency	Romsey and Southampton North
	tabling member printed	Caroline Nokes
	uin	23729
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The final meeting of the National Learning Disability Board took place on 19 July 2016. More information is available at the following link:</p><p><a href="https://www.gov.uk/government/groups/learning-disability-programme-board#minutes" target="_blank">https://www.gov.uk/government/groups/learning-disability-programme-board#minutes</a></p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 30/04/2024 16:48:01 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4048 label Biography information for Caroline Nokes

1713890

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Learning Disability: Nurses
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many learning disability nurses there (a) are and (b) were in each of the last five years.
	tabling member constituency	Romsey and Southampton North
	tabling member printed	Caroline Nokes
	uin	23730
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>NHS England publishes monthly Hospital and Community Health Services workforce statistics for England. These include staff working for hospital trusts and core organisations, but excludes staff working for other providers such as in primary care, general practice, or social care. This data is drawn from the Electronic Staff Record, the human resources system for the National Health Service. The statistics are available at the following link:</p><p> </p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics</a></p><p> </p><p>A large proportion of learning disability nurses work outside NHS trusts, and we do not hold data on where they work. However, the Nursing and Midwifery Council publishes data on the number of nurses on the register across the United Kingdom, which will include nurses employed in other settings, such as education. Data is available in the Fields of Practice sheet in the permanent register data tables, at the following link:</p><p><a href="https://www.nmc.org.uk/about-us/reports-and-accounts/registration-statistics/" target="_blank">https://www.nmc.org.uk/about-us/reports-and-accounts/registration-statistics/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 23731 question first answered 30/04/2024 09:48:48 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4048 label Biography information for Caroline Nokes

1713891

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Learning Disability: Nurses
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of learning disability nurses are in senior leadership roles.
	tabling member constituency	Romsey and Southampton North
	tabling member printed	Caroline Nokes
	uin	23731
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>NHS England publishes monthly Hospital and Community Health Services workforce statistics for England. These include staff working for hospital trusts and core organisations, but excludes staff working for other providers such as in primary care, general practice, or social care. This data is drawn from the Electronic Staff Record, the human resources system for the National Health Service. The statistics are available at the following link:</p><p> </p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics</a></p><p> </p><p>A large proportion of learning disability nurses work outside NHS trusts, and we do not hold data on where they work. However, the Nursing and Midwifery Council publishes data on the number of nurses on the register across the United Kingdom, which will include nurses employed in other settings, such as education. Data is available in the Fields of Practice sheet in the permanent register data tables, at the following link:</p><p><a href="https://www.nmc.org.uk/about-us/reports-and-accounts/registration-statistics/" target="_blank">https://www.nmc.org.uk/about-us/reports-and-accounts/registration-statistics/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 23730 question first answered 30/04/2024 09:48:48 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4048 label Biography information for Caroline Nokes

1713892

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Autism and Learning Disability: Training
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an estimate of the number of health and adult social care staff that will undertake the second part of tier (a) one and (b) two of the Oliver McGowan Mandatory Training on Learning Disability and Autism in the next three years.
	tabling member constituency	Romsey and Southampton North
	tabling member printed	Caroline Nokes
	uin	23732
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>We have provided estimates of the number of health and adult social care staff that would undertake Tier 1 and Tier 2 of the Oliver McGowan Mandatory Training in our consultation stage impact assessment. This assessment was published as part of the public consultation on the Oliver McGowan Code of Practice. The impact assessment and wider public consultation are available, respectively, at the following two links:</p><p><a href="https://assets.publishing.service.gov.uk/media/649a8c399e7a8b0013932bec/impact-assessment-oliver-mcgowan-draft-code-of-practice.pdf" target="_blank">https://assets.publishing.service.gov.uk/media/649a8c399e7a8b0013932bec/impact-assessment-oliver-mcgowan-draft-code-of-practice.pdf</a></p><p><a href="https://www.gov.uk/government/consultations/oliver-mcgowan-draft-code-of-practice/oliver-mcgowan-draft-code-of-practice-on-statutory-learning-disability-and-autism-training" target="_blank">https://www.gov.uk/government/consultations/oliver-mcgowan-draft-code-of-practice/oliver-mcgowan-draft-code-of-practice-on-statutory-learning-disability-and-autism-training</a></p><p>For healthcare, we estimated that over the first three years of training roll-out, 1,036,000 staff would be trained at Tier 1 level, and 1,186,000 staff would be trained at Tier 2 level. For adult social care, over the same period, we estimated that 840,000 staff would be trained at Tier 1 level, and 492,000 staff would be trained at Tier 2 level. In addition, over 1.7 million people have already completed the first part of Oliver McGowan Mandatory Training on Learning Disability and Autism, an e-learning package.</p><p>The final stage impact assessment incorporates additional evidence on the number of staff expected to undertake training, which was provided by organisations through the public consultation. The final assessment will be published in due course.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 30/04/2024 10:04:00 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4048 label Biography information for Caroline Nokes

1713908

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liver Cancer: Mortality Rates
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she has made an estimate of expected liver cancer mortality rates by the end of 2025.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	23699
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>No estimate has been made of expected liver cancer mortality rates by the end of 2025. The care of and treatment for patients with cancer, including liver cancer, is a priority for the Government. Early diagnosis of liver cancer is critical to improving rates of survival. NHS England’s Early Diagnosis of Liver Cancer Programme is contributing to the NHS Long Term Plan’s commitment to diagnose 75% of all cancers at stage one or two by 2028. This programme includes three workstreams: improving liver surveillance programmes; community liver health checks pilots; and primary care pilots. Identifying those at risk and ensuring patients are tested and referred to a surveillance programme, where necessary, will lead to improved patient outcomes.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 30/04/2024 09:55:44 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	1409 label Biography information for Mr Gregory Campbell

1713932

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Trials
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the paper entitled The Future of Clinical Research Delivery: 2022 to 2025 implementation plan, published on 30 June 2022, what progress has been made on the Find, Recruit and Follow-up service for clinical trials.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	23739
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Since publication of the Future of Clinical Research Delivery, we have developed early versions of several products as part of the Find, Recruit and Follow-up Service, to deliver secure data enabled study feasibility and recruitment within established governance and legal requirements, across England and other parts of the United Kingdom.</p><p> </p><p>These products include: NHS England’s DigiTrials self-service feasibility tool, which identifies suitable locations for studies by establishing where the largest groupings of eligible people are based; NHS England’s DigiTrials recruitment service, which is currently in its second phase of pilots and will enable the National Health Service to more easily approach patients about research relevant to them; the Medicines and Healthcare products Regulatory Agency’s Clinical Research Practice Datalink, which allows participating general practices to identify potentially eligible patients for relevant studies more easily; and the Be Part of Research registry, which allows people to proactively register their interest in participating in research.</p><p> </p><p>These tools have been developed to increase the efficiency and effectiveness of the clinical research process, and also improve our ability to widen access to research opportunities, increase the resilience and sustainability of the healthcare system, and reduce the burden on the NHS workforce.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 30/04/2024 10:48:51 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4124 label Biography information for Chi Onwurah

1713933

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Trials: Contracts
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the policy paper entitled Full government response to the Lord O'Shaughnessy review into commercial clinical trials, last updated on 8 December 2023, what her Department's planned timetable is for expanding the national contract value review programme to phase 1 and 2a clinical trials.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	23740
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The National Contract Value Review (NCVR) process applies to commercial clinical studies. NHS England is working in partnership with the devolved administrations, the National Institute for Health and Care Research, and other partners, to pilot the use of the NCVR process for phase I and IIa of commercial clinical trials. The ambition is to make the use of NCVR for phase I and IIa of commercial clinical trials mainstream from October 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 30/04/2024 09:57:50 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4124 label Biography information for Chi Onwurah

1713936

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicines and Healthcare Products Regulatory Agency: Accountability
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how the Medicines and Healthcare products Regulatory Agency is held accountable for its decisions.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23760
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) performs the functions of my Rt hon. Friend, the Secretary of State for Health and Social Care, under United Kingdom legislation, relating to the regulation of medicines, medical devices, and blood products for transfusion. The MHRA also performs the functions of my Rt hon. Friend, the Secretary of State for Health and Social Care in relation to the standardisation and control of biological medicines including vaccines, blood products, and other substances which cannot be characterised chemically, and which require special testing measures to ensure their safety and efficacy.</p><p>My Rt hon. Friend, the Secretary of State for Health and Social Care has ministerial responsibility for, and oversight of, the MHRA’s delivery and performance. The MHRA seeks ministerial agreement for policy and legislative framework changes. Ministers are not involved in individual decisions made by the MHRA. The MHRA is held to account through regular established mechanisms including quarterly and annual accountability reviews. A framework agreement between the Department and the MHRA also sets out the governance structure within which both parties operate, with further information available at the following link:</p><p><a href="https://www.gov.uk/government/publications/dh-and-mhra-framework-agreement/framework-agreement-between-dhsc-and-the-medicines-and-healthcare-products-regulatory-agency" target="_blank">https://www.gov.uk/government/publications/dh-and-mhra-framework-agreement/framework-agreement-between-dhsc-and-the-medicines-and-healthcare-products-regulatory-agency</a></p><p>The MHRA also publishes performance figures each month, as well as its annual report and accounts, and the minutes of the latest Annual Accountability Review with the MHRA is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/annual-accountability-review-mhra/annual-accountability-review-minutes-2022-to-2023-3-july-2023" target="_blank">https://www.gov.uk/government/publications/annual-accountability-review-mhra/annual-accountability-review-minutes-2022-to-2023-3-july-2023</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 23761 question first answered 30/04/2024 09:52:08 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4471 label Biography information for Rachael Maskell

1713937

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicines and Healthcare Products Regulatory Agency
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps is she taking to review the decisions of the Medicines and Healthcare products Regulatory Agency.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23761
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) performs the functions of my Rt hon. Friend, the Secretary of State for Health and Social Care, under United Kingdom legislation, relating to the regulation of medicines, medical devices, and blood products for transfusion. The MHRA also performs the functions of my Rt hon. Friend, the Secretary of State for Health and Social Care in relation to the standardisation and control of biological medicines including vaccines, blood products, and other substances which cannot be characterised chemically, and which require special testing measures to ensure their safety and efficacy.</p><p>My Rt hon. Friend, the Secretary of State for Health and Social Care has ministerial responsibility for, and oversight of, the MHRA’s delivery and performance. The MHRA seeks ministerial agreement for policy and legislative framework changes. Ministers are not involved in individual decisions made by the MHRA. The MHRA is held to account through regular established mechanisms including quarterly and annual accountability reviews. A framework agreement between the Department and the MHRA also sets out the governance structure within which both parties operate, with further information available at the following link:</p><p><a href="https://www.gov.uk/government/publications/dh-and-mhra-framework-agreement/framework-agreement-between-dhsc-and-the-medicines-and-healthcare-products-regulatory-agency" target="_blank">https://www.gov.uk/government/publications/dh-and-mhra-framework-agreement/framework-agreement-between-dhsc-and-the-medicines-and-healthcare-products-regulatory-agency</a></p><p>The MHRA also publishes performance figures each month, as well as its annual report and accounts, and the minutes of the latest Annual Accountability Review with the MHRA is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/annual-accountability-review-mhra/annual-accountability-review-minutes-2022-to-2023-3-july-2023" target="_blank">https://www.gov.uk/government/publications/annual-accountability-review-mhra/annual-accountability-review-minutes-2022-to-2023-3-july-2023</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 23760 question first answered 30/04/2024 09:52:08 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4471 label Biography information for Rachael Maskell

1714010

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Shortages
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of shortages in the supply of prescription drugs.
	tabling member printed	The Lord Bishop of Southwark
	uin	HL4117
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>There are approximately 14,000 medicines licensed for supply in the United Kingdom, and the overwhelming majority are in good supply. The medicine supply chain is complex, global, and highly regulated, and supply issues can be caused by a range of factors. For example, suppliers can encounter manufacturing problems, difficulty accessing raw materials, and surges in demand. These are commonly cited as the drivers of the recent supply issues, which have affected many countries, not just the UK.</p><p>Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.</p> answering member printed Lord Markham question first answered 30/04/2024 11:37:26 answering member 4948 label Biography information for Lord Markham
	tabling member	4345 label Biography information for The Lord Bishop of Southwark

1713402

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Disability
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what her planned timetable is for publishing the revised NHS Accessible Information Standard.
	tabling member constituency	Preston
	tabling member printed	Sir Mark Hendrick
	uin	23386
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>NHS England remains committed to publishing the Accessible Information Standard (AIS) as soon as possible, with the intention of publishing it within the first quarter of 2024/25. The standard is within the publication process, and NHS England are working to both progress the documentation through the publication approval process, as well as ensuring that, when published, the AIS and supporting documentation are available in accessible formats.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 29/04/2024 16:31:07 answering member 4492 label Biography information for Maria Caulfield
	tabling member	473 label Biography information for Sir Mark Hendrick

1713406

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what her timetable is for the rollout of Endo Barriers on the NHS.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	23480
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The implantation of a duodenal–jejunal bypass liner, also known as an endo barrier, for managing type 2 diabetes, is not recommended by the NICE, and therefore not available on the National Health Service. Current evidence on the safety and efficacy of the device for managing type 2 diabetes is limited in quality and quantity. For this reason, the NICE recommends that the procedure should only be done as part of a research study. Further information on the NICE guidelines is available at the following link:</p><p><a href="https://www.nice.org.uk/guidance/ipg518/chapter/1-Recommendations" target="_blank">https://www.nice.org.uk/guidance/ipg518/chapter/1-Recommendations</a></p><p>The NICE may update the guidance, upon publication of further evidence. The NICE recommends that people with type 2 diabetes receive eight care processes at least annually, to support them to achieve three treatment targets to prevent diabetes related complications. The care processes include checks on blood glucose and body mass index, to support weight management. Delivery of all eight care processes is associated with reduced emergency admissions, amputations, and retinopathy. NHS England commissions two national lifestyle services to support adults with type 2 diabetes to manage their weight and improve their health and wellbeing. These are the NHS Digital Weight Management Programme and the NHS Type 2 Diabetes Path to Remission Programme. The NICE guidance for the care and management for adults with type 2 diabetes is available at the following link:</p><p><a href="https://www.nice.org.uk/guidance/ng28" target="_blank">https://www.nice.org.uk/guidance/ng28</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 30/04/2024 16:33:44 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4131 label Biography information for Jim Shannon

1713407

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ambulance Services: Databases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether NHS England has issued a data privacy notice for ambulance services data to be part of the NHS Federated Data Platform product.
	tabling member constituency	Haltemprice and Howden
	tabling member printed	Sir David Davis
	uin	23378
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>NHS England has published an Ambulance Data Service dashboard, Federated Data Platform product privacy notice, which is available at the following link:</p><p><a href="https://www.england.nhs.uk/contact-us/privacy-notice/how-we-use-your-information/nhs-federated-data-platform-privacy-notice/fdp-products-and-product-privacy-notices/ambulance-data-services-ads-dashboard-fdp-product-privacy-notice/" target="_blank">https://www.england.nhs.uk/contact-us/privacy-notice/how-we-use-your-information/nhs-federated-data-platform-privacy-notice/fdp-products-and-product-privacy-notices/ambulance-data-services-ads-dashboard-fdp-product-privacy-notice/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 29/04/2024 16:02:46 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	373 label Biography information for Sir David Davis

1713468

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Social Services: Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether her Department has issued recent guidance to integrated care boards on their role in assessing the mental and emotional health of young people entering care using a person qualified to assess mental health as part of the initial health assessment.
	tabling member constituency	Canterbury
	tabling member printed	Rosie Duffield
	uin	23541
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The statutory guidance, Promoting the health and wellbeing of looked after children, published in 2015, reflects the requirement that the relevant local authority must make arrangements for the initial health assessment to be carried out by a registered medical professional who is suitably qualified to assess a young person's physical, emotional, and mental health needs.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 29/04/2024 16:29:40 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4616 label Biography information for Rosie Duffield

1713508

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Telemedicine: Voice over Internet Protocol
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she plans to introduce legislation that will prohibit the sale of telecare devices that are incompatible with VoIP.
	tabling member constituency	Rhondda
	tabling member printed	Sir Chris Bryant
	uin	23436
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Government is committed to ensuring the safety of telecare users in the transition from the Public Switched Telephone Network (PSTN) to digital phonelines. The Department has been engaging with the telecare industry to raise awareness of the PSTN migration, and to encourage telecare suppliers to offer digitally compatible telecare equipment. The Department is not currently pursuing legislative routes for prohibiting the sale of telecare devices that are incompatible with Voice over Internet Protocol.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 30/04/2024 18:32:55 answering member 4527 label Biography information for Helen Whately previous answer version 31583 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527 label Biography information for Helen Whately
	tabling member	1446 label Biography information for Sir Chris Bryant

1713513

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make it her policy to enable second opinions in mental health settings.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23519
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The second opinion appointed doctor (SOAD) service safeguards the rights of patients subject to the Mental Health Act in specific circumstances. A SOAD is an independent doctor appointed by the Care Quality Commission, who gives a second opinion on whether certain types of medical treatment for a mental disorder should be given without the patient’s consent. SOADs are consulted in certain circumstances when a patient refuses treatment, or is too ill or otherwise incapable of giving consent. Outside of these specific circumstances, if an individual disagrees with their doctor about a mental health diagnosis or treatment, they can ask for a second opinion, although there is no legal right to one.</p><p>Good Medical Practice, from the General Medical Council (GMC), sets out the standards of care and behaviour expected of all medical doctors practising in the United Kingdom. It states that doctors must recognise a patient’s right to choose whether to accept their advice, and respect a patient’s right to seek a second opinion. The GMC is an independent regulator, and is responsible for operational maters including any assessment of its policies and guidance. Managing second opinion requests is the responsibility of local National Health Service organisations.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 29/04/2024 16:28:27 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4471 label Biography information for Rachael Maskell

1713514

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Psychiatric Patients: Discharges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that people with significant mental health issues are not discharged to the community.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23520
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>Clinicians will decide when a person is medically fit for discharge. On 26 January 2024, new statutory guidance was published for those being discharged from mental health inpatient settings. This sets out how health and care systems can work effectively together to support the discharge process from hospital, and ensure the right support in the community. The guidance also includes best practice in relation to patient and carer involvement in discharge planning.</p><p>NHS England has asked all systems to review their community mental health services, to ensure that they have clear policies and practice in place for patients with serious mental illness, who require intensive community treatment and follow-up, but where engagement is a challenge. NHS England will provide national guidance to support reviews, which will be completed by Autumn 2024. NHS England will consider further steps as appropriate, following the completion of the reviews.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 29/04/2024 14:36:56 answering member 4527 label Biography information for Helen Whately
	tabling member	4471 label Biography information for Rachael Maskell

1713568

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Standards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to help improve patient access to primary care services.
	tabling member constituency	Slough
	tabling member printed	Mr Tanmanjeet Singh Dhesi
	uin	23549
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>Our Delivery plan for recovering access to primary care has two central ambitions to improve access to general practice (GP): tackling the 8:00am rush and reducing the number of people struggling to contact their practice; and for patients to know on the day they contact their practice, how their request will be managed.</p><p>We are doing this by modernising telephone systems, backed by £240 million in retargeted funding, and by building the capacity to deliver more appointments. As a result, we have now delivered on our manifesto commitment for 50 million more GP appointments per year, with 370.7 million booked across the last 12 months.</p><p>There is an increasing number of clinical services that are being delivered in community pharmacy, including the New Medicines Service, Contraception Service, Blood Pressure Check Service, Stop Smoking Service, and most recently the new Pharmacy First service. These services help take the pressure off GPs, and make it quicker and easier for patients to access care.</p><p>Furthermore, our plan to recover and reform NHS dentistry will fund approximately 2.5 million additional appointments. The plan sets out our actions to address the challenges facing National Health Service dentistry, and to improve dental access for patients across the country. A new patient premium is supporting dentists to take on new patients, and a new marketing campaign will help everyone who needs an NHS dentist in finding one. We have further supported dentists by raising the minimum Units of Dental Activity rate to £28 this year, making NHS work more attractive and sustainable.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 29/04/2024 15:40:25 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1713579

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Personal Records
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what evidence of (a) identity and (b) immigration status GPs require from patients seeking to access their services; and whether her Department provides guidance to GPs on ensuring that identification provided by those people is genuine.
	tabling member constituency	Christchurch
	tabling member printed	Sir Christopher Chope
	uin	23367
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>Patients have the legal right to choose a general practice (GP) that best suits their needs. An individual should not be refused registration or appointments because they do not have proof of address or personal identification. Patients do not need to provide proof of address or immigration status, identification, or a National Health Service number to register with a GP. The vast majority of migrants are required to pay the Immigration Health Surcharge when applying for a visa to stay in the United Kingdom for longer than six months.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 29/04/2024 16:10:48 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	242 label Biography information for Sir Christopher Chope

1713583

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Trusts: Cybercrime
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many times NHS trusts have been victims of ransomware attacks in the last 12 months; and whether (a) data has been (i) lost and (ii) made public and (b) a ransom has been paid in each case.
	tabling member constituency	East Yorkshire
	tabling member printed	Sir Greg Knight
	uin	23406
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>A small number of cyber-attacks against National Health Service hospitals have been made public, but the specific details on the number, nature, and subsectors of NHS organisations that have been victims of a ransomware attack in the last twelve months cannot be released, as it may prejudice the prevention or detection of cyber-attacks against the NHS.</p><p>Our around-the-clock cyber monitoring across over 1.5 million NHS computers allows us to identify that ransomware is the most significant cyber security threat currently facing the health and social care sector. Automated cyber defences and monitoring by NHS England’s Cyber Operations teams continuously deter, prevent, and disrupt attempts to break into the NHS’ IT systems. The NHS implements the Government’s policy of not condoning ransom payment.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 29/04/2024 15:51:14 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	1200 label Biography information for Sir Greg Knight

1713606

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of reviewing general practice funding streams to account for potential additional resource requirements in socio-economically deprived communities.
	tabling member constituency	Portsmouth South
	tabling member printed	Stephen Morgan
	uin	23562
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The Department is committed to ensuring patients living in deprived areas have access to good health care. The Carr-Hill formula, which is used to calculate core funding for practices, reflects differences in the age and sex composition of the practice’s registered patient list, together with a range of factors that take into account the additional pressures generated by differential rates of patient turnover, morbidity, mortality, and the impact of geographical location. Under this formula, practices whose registered patients have greater healthcare needs are paid more per patient than practices whose registered patients have fewer healthcare needs.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 29/04/2024 15:41:59 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4653 label Biography information for Stephen Morgan

1713626

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Stepping Hill Hospital: Bowel Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment her Department has made of the adequacy of (a) diagnosis and (b) treatment services for bowel cancer at Stepping Hill hospital.
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	uin	23605
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>No specific assessment has been made of the adequacy of diagnosis and treatment services for bowel cancer at Stepping Hill Hospital. However, data held at the provider level can give us insight into lower gastrointestinal (GI) cancer for Stockport NHS Foundation Trust. Of those patients referred to Stockport NHS Foundation Trust for suspected lower GI cancer in February 2024, 86.1% received a diagnosis or ruling out of cancer within 28 days. This is above the 75.0% standard, and shows an increase of 4.2% since January. Furthermore, of those patients referred to Stockport NHS Foundation Trust for lower GI cancer in February 2024, 95.2% received a first or subsequent treatment within 31 days of a decision to treat. This is above national performance of 91.1%, against the standard of 96.0%. For lower GI cancer in the same period, 67.4% of patients received treatment within 62 days of an urgent suspected cancer or screening referral, or consultant upgrade, to a first definitive treatment for cancer. This is above national performance of 63.9% against the standard of 85.0%.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 30/04/2024 10:00:33 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4811 label Biography information for Navendu Mishra

1713634

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Colonoscopy: Greater Manchester
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the average waiting time is to receive results from a colonoscopy in (a) Stepping Hill Hospital and (b) Greater Manchester.
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	uin	23613
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The data requested is not currently collected by either Stockport NHS Foundation Trust Stepping Hill Hospital, or by the Greater Manchester Integrated Care Board.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 30/04/2024 16:03:46 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4811 label Biography information for Navendu Mishra

1713648

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy: Coventry North West
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an estimate of the number of pharmacies that have closed in Coventry North West constituency since 2019; and if she will make an assessment of the potential impact of pharmacy closures on primary care standards.
	tabling member constituency	Coventry North West
	tabling member printed	Taiwo Owatemi
	uin	23619
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>On 31 December 2023, there were 22 pharmacies in Coventry North West constituency, including one distance selling pharmacy. Between 31 December 2019 and 31 December 2023, two pharmacies closed in Coventry North West and no new pharmacies opened. However, access to pharmaceutical services remains good, with 97% of the population of Coventry North West living within a 20-minute walk from a pharmacy. This exceeds the national average of 80%. Residents of Coventry North West can also access services from distance selling pharmacies that operate nationally.</p><p>It is the role of local authorities in England to undertake pharmaceutical needs assessments for their areas, every three years, to ensure provision continues to meet their population’s needs. Integrated care boards (ICBs) have regard to those assessments when commissioning services and where a pharmacy closure impacts on the access to services, a new contractor can apply to open a pharmacy in the area.</p><p>Services within the National Health Service delivered in community pharmacy can have a positive impact on secondary care. For example, the Discharge Medicines Service and the New Medicine Service provide patients with extra support for medicines preventing (re)hospitalisation. Urgent and emergency care settings can also refer patients to community pharmacies for a minor illness consultation or an urgent medicine supply, taking the pressure off secondary care. Increasing the impact of these services, which are already commissioned in community pharmacies, will require continued embedding of referral in secondary care pathways.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 23620 question first answered 29/04/2024 15:43:42 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4779 label Biography information for Taiwo Owatemi

1713649

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of increasing funding for community pharmacies on funding for secondary care.
	tabling member constituency	Coventry North West
	tabling member printed	Taiwo Owatemi
	uin	23620
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>On 31 December 2023, there were 22 pharmacies in Coventry North West constituency, including one distance selling pharmacy. Between 31 December 2019 and 31 December 2023, two pharmacies closed in Coventry North West and no new pharmacies opened. However, access to pharmaceutical services remains good, with 97% of the population of Coventry North West living within a 20-minute walk from a pharmacy. This exceeds the national average of 80%. Residents of Coventry North West can also access services from distance selling pharmacies that operate nationally.</p><p>It is the role of local authorities in England to undertake pharmaceutical needs assessments for their areas, every three years, to ensure provision continues to meet their population’s needs. Integrated care boards (ICBs) have regard to those assessments when commissioning services and where a pharmacy closure impacts on the access to services, a new contractor can apply to open a pharmacy in the area.</p><p>Services within the National Health Service delivered in community pharmacy can have a positive impact on secondary care. For example, the Discharge Medicines Service and the New Medicine Service provide patients with extra support for medicines preventing (re)hospitalisation. Urgent and emergency care settings can also refer patients to community pharmacies for a minor illness consultation or an urgent medicine supply, taking the pressure off secondary care. Increasing the impact of these services, which are already commissioned in community pharmacies, will require continued embedding of referral in secondary care pathways.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 23619 question first answered 29/04/2024 15:43:42 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4779 label Biography information for Taiwo Owatemi

1713650

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what medications have been reimbursed to community pharmacies below the market price for pharmacy procurement in (a) 2021, (b) 2022, (c) 2023 and (d) 2024.
	tabling member constituency	Coventry North West
	tabling member printed	Taiwo Owatemi
	uin	23621
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The information requested is not held centrally. Community pharmacy reimbursement arrangements, set out in the Drug Tariff, are not designed to pay every individual pharmacy the cost, or more than the cost, of the medicine. This means that at an individual level, there will be instances where a pharmacy pays more than they are reimbursed, and other instances where they are paid less than they are reimbursed.</p><p>The medicine margin survey assesses the amount of medicine margin, the difference between the reimbursement price and the price the pharmacy was charged by the supplier, retained by community pharmacies. The survey has found that overall, more than the amount agreed as part of the Community Pharmacy Contractual Framework, has been delivered in total across the previous four financial years.</p><p>In addition to this, where a number of pharmacies cannot purchase at or below the Drug Tariff reimbursement price, the Department considers concessionary price requests that come directly from the Community Pharmacy England, on behalf of community pharmacies. From 1 April 2024, we introduced a new retrospective top-up payment for concessionary prices, providing an additional payment to contractors when the margin survey indicates that despite a concessionary price, there was an under payment.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 29/04/2024 15:18:30 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4779 label Biography information for Taiwo Owatemi

1713701

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Nurses: Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of introducing a separate nursing pay spine on trends in the level of pay progression within the nursing profession.
	tabling member constituency	Bury South
	tabling member printed	Christian Wakeford
	uin	23663
	answer	answer is ministerial correction date of answer 26/04/2024 answer text <p>The call for evidence in relation to a separate pay spine for nursing closed on 4 April 2024. A large volume of evidence was submitted, and analysis of this evidence remains underway. The Government will publish its formal response in due course.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 26/04/2024 12:16:03 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4871 label Biography information for Christian Wakeford

1713705

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure parity between (a) clinical and (b) recently insourced nonclinical staff in the one-off covid bonus payment.
	tabling member constituency	Bury South
	tabling member printed	Christian Wakeford
	uin	23667
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The non-consolidated payments, agreed as part of the Agenda for Change pay deal, covered staff directly employed by National Health Service organisations, for instance staff on permanent and fixed term contracts, as set out in Annex 1 of the handbook on Agenda for Change terms as of 31 March 2023. Those who joined the NHS after 31 March 2023 were ineligible for the award, regardless of their profession.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 29/04/2024 15:20:44 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4871 label Biography information for Christian Wakeford

1713721

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Aviation: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of operation of law in relation to the provision of adrenaline auto-injectors on commercial aircraft.
	tabling member printed	Lord Kennedy of Southwark
	uin	HL4071
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.</p><p>The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4072 HL4073 HL4074 question first answered 30/04/2024 11:25:28 answering member 4948 label Biography information for Lord Markham
	tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713722

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Adrenaline: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of operation of law in relation to the provision of adrenaline auto-injectors on trains.
	tabling member printed	Lord Kennedy of Southwark
	uin	HL4072
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.</p><p>The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4071 HL4073 HL4074 question first answered 30/04/2024 11:25:28 answering member 4948 label Biography information for Lord Markham
	tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713723

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Aviation: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what requirements there are for airlines to ensure adrenaline auto-injectors are available on commercial flights.
	tabling member printed	Lord Kennedy of Southwark
	uin	HL4073
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.</p><p>The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4071 HL4072 HL4074 question first answered 30/04/2024 11:25:28 answering member 4948 label Biography information for Lord Markham
	tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713724

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Airports: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what requirements there are for airports to ensure adrenaline auto-injectors are available on their premises.
	tabling member printed	Lord Kennedy of Southwark
	uin	HL4074
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.</p><p>The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4071 HL4072 HL4073 question first answered 30/04/2024 11:25:28 answering member 4948 label Biography information for Lord Markham
	tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713725

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	First Aid: Adrenaline
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what guidance they have issued on the administering of adrenaline auto-injectors by minors in medical emergencies.
	tabling member printed	Lord Kennedy of Southwark
	uin	HL4075
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance on the use of adrenaline auto-injectors in schools, and there is provision in this guidance for the use of an adrenaline auto-injector on someone to whom it was not prescribed, in a medical emergency. However, regulation 238 of the Human Medicines Regulations 2012 provides an exemption from certain requirements related to the administration of medicines. Specifically, it allows for parenteral, rather than injected or absorbed, administration of specified medicines in emergency situations, where the purpose is to save a life. For instance, adrenaline prescribed for a specific person, or even to an unknown person, can be administered under this regulation, if it is necessary to save a life during an emergency. The use in emergencies is covered by schedule 19 and regulation 238, where age is not specified.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the MHRA, Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4076 question first answered 30/04/2024 11:36:16 answering member 4948 label Biography information for Lord Markham
	tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713726

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	First Aid: Adrenaline
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what guidance they have issued regarding the use of an adrenaline auto-injector on someone to whom it was not prescribed in a medical emergency.
	tabling member printed	Lord Kennedy of Southwark
	uin	HL4076
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance on the use of adrenaline auto-injectors in schools, and there is provision in this guidance for the use of an adrenaline auto-injector on someone to whom it was not prescribed, in a medical emergency. However, regulation 238 of the Human Medicines Regulations 2012 provides an exemption from certain requirements related to the administration of medicines. Specifically, it allows for parenteral, rather than injected or absorbed, administration of specified medicines in emergency situations, where the purpose is to save a life. For instance, adrenaline prescribed for a specific person, or even to an unknown person, can be administered under this regulation, if it is necessary to save a life during an emergency. The use in emergencies is covered by schedule 19 and regulation 238, where age is not specified.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the MHRA, Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4075 question first answered 30/04/2024 11:36:16 answering member 4948 label Biography information for Lord Markham
	tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713739

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	School Milk
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what are the reasons for administering the Nursery Milk Scheme to children only until their fifth birthday rather than until the end of the academic year in which that birthday falls.
	tabling member printed	Lord Watson of Invergowrie
	uin	HL4089
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The Nursery Milk Scheme allows early years childcare settings such as childminders and nurseries to reclaim the cost of providing one-third of a pint of milk to children under five years old who attend their childcare setting for at least two hours per day. Schools are also allowed to claim under this scheme in respect of pupils under the age of five years old. There are no current plans to extend the Nursery Milk Scheme to cover other school pupils.</p><p>The School Food Standards require lower-fat or lactose free milk to be available in all schools. From the age of five years old onwards, pupils eligible for benefits-based free school meals are eligible for free school milk. In addition, the school milk subsidy scheme subsidises the cost of milk and certain milk products for children in primary and secondary schools including over fives. This means that participating schools can sell the products in schools at a lower price. More information on this scheme is available on GOV.UK in an online-only format.</p> answering member printed Lord Markham question first answered 29/04/2024 16:41:17 answering member 4948 label Biography information for Lord Markham
	tabling member	1241 label Biography information for Lord Watson of Invergowrie

1713139

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Palliative Care: Integrated Care Boards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that integrated care boards have clear accountability over their funding decisions for (a) hospices and (b) palliative and end of life care services.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23228
	answer	answer is ministerial correction date of answer 26/04/2024 answer text <p>Integrated care boards (ICBs) are responsible for determining the level of locally available, National Health Service funded palliative and end of life care, including hospice care. ICBs are responsible for ensuring that the services they commission meet the needs of their local population.</p><p>The majority of palliative and end of life care is provided by NHS staff and services. However, we also recognise the vital part that voluntary sector organisations, including hospices, play in providing support to people at end of life, and their families. Most hospices are charitable, independent organisations which receive some statutory funding for providing NHS services. The amount of funding hospices receive is dependent on many factors, including what other statutory services are available within the ICB footprint. Charitable hospices provide a range of services which go beyond that which statutory services are legally required to provide. Consequently, the funding arrangements reflect this.</p><p>In July 2022, NHS England published statutory guidance and service specifications for commissioners on palliative and end of life care, setting out the considerations for ICBs to meet their legal duties, and making clear reference to the importance of access to services.</p><p>The Department and NHS England, alongside key partners, will continue to proactively engage with our stakeholders, including the voluntary sector and independent hospices, on an ongoing basis, in order to understand the issues they face, including that of future funding pressures. The Department is in ongoing discussions with NHS England, including its National Clinical Director, about the oversight and accountability of National Health Service palliative and end of life care commissioning.</p><p>From April 2024, NHS England will include palliative and end of life care in the list of topics for its regular performance discussions between national and regional leads. These national meetings will provide an additional mechanism for supporting ICBs in continuing to improve palliative and end of life care for their local population.</p><p>NHS England has commissioned the development of a palliative and end of life care dashboard, which brings together relevant local data in one place. The dashboard helps commissioners understand the palliative and end of life care needs of those in their local population, enabling ICBs to put plans in place to address and track the improvement of health inequalities. Additionally, the National Institute for Health and Care Research has established a new Policy Research Unit to build an evidence base on palliative and end of life care, with a specific focus on inequalities.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 23229 23232 question first answered 26/04/2024 09:56:37 answering member 4527 label Biography information for Helen Whately
	tabling member	4471 label Biography information for Rachael Maskell

1713141

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Palliative Care: Integrated Care Boards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will provide financial support to integrated care boards to tackle regional inequalities in (a) hospice, (b) palliative and (c) end of life care services.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23229
	answer	answer is ministerial correction date of answer 26/04/2024 answer text <p>Integrated care boards (ICBs) are responsible for determining the level of locally available, National Health Service funded palliative and end of life care, including hospice care. ICBs are responsible for ensuring that the services they commission meet the needs of their local population.</p><p>The majority of palliative and end of life care is provided by NHS staff and services. However, we also recognise the vital part that voluntary sector organisations, including hospices, play in providing support to people at end of life, and their families. Most hospices are charitable, independent organisations which receive some statutory funding for providing NHS services. The amount of funding hospices receive is dependent on many factors, including what other statutory services are available within the ICB footprint. Charitable hospices provide a range of services which go beyond that which statutory services are legally required to provide. Consequently, the funding arrangements reflect this.</p><p>In July 2022, NHS England published statutory guidance and service specifications for commissioners on palliative and end of life care, setting out the considerations for ICBs to meet their legal duties, and making clear reference to the importance of access to services.</p><p>The Department and NHS England, alongside key partners, will continue to proactively engage with our stakeholders, including the voluntary sector and independent hospices, on an ongoing basis, in order to understand the issues they face, including that of future funding pressures. The Department is in ongoing discussions with NHS England, including its National Clinical Director, about the oversight and accountability of National Health Service palliative and end of life care commissioning.</p><p>From April 2024, NHS England will include palliative and end of life care in the list of topics for its regular performance discussions between national and regional leads. These national meetings will provide an additional mechanism for supporting ICBs in continuing to improve palliative and end of life care for their local population.</p><p>NHS England has commissioned the development of a palliative and end of life care dashboard, which brings together relevant local data in one place. The dashboard helps commissioners understand the palliative and end of life care needs of those in their local population, enabling ICBs to put plans in place to address and track the improvement of health inequalities. Additionally, the National Institute for Health and Care Research has established a new Policy Research Unit to build an evidence base on palliative and end of life care, with a specific focus on inequalities.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 23228 23232 question first answered 26/04/2024 09:56:37 answering member 4527 label Biography information for Helen Whately
	tabling member	4471 label Biography information for Rachael Maskell

1713142

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Palliative Care: Health Education
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she is taking steps to increase health literacy for services to support people at the end of life.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23230
	answer	answer is ministerial correction date of answer 26/04/2024 answer text <p>The National Health Service website and the NHS App are our main digital tools available to citizens, to support them in accessing services and making decisions about their health. Clinicians across the NHS also support patients’ health literacy by providing clear information, increasing patients’ knowledge, and sharing decision-making on their care.</p><p>Additionally, through the Voluntary Community Social Enterprise (VCSE) Health and Wellbeing Programme, the Department, NHS England, and the UK Health Security Agency work together with VCSE organisations to drive transformation of health and care systems, promote equality, address health inequalities, and help people, families, and communities to achieve and maintain wellbeing. The current projects include increasing health literacy through intersectional considerations at the end of life, digital inclusion, and barriers for those likely to be in the last year of life without a life-limiting diagnosis.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 26/04/2024 10:05:06 answering member 4527 label Biography information for Helen Whately
	tabling member	4471 label Biography information for Rachael Maskell

1713143

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Palliative Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will take steps to ensure that best practice in palliative and end of life care is shared across the NHS.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23231
	answer	answer is ministerial correction date of answer 26/04/2024 answer text <p>The Government recognises that access to high-quality palliative and end of life care can make all the difference to individuals and their loved ones. NHS England meets regularly with regional and system leaders, providing a forum for the sharing of best practice. In addition, there is a palliative and end of life care workspace available on the FutureNHS Collaborative Platform, which includes a range of resources, case studies, and discussion fora, with access to the platform available for anyone with a NHS.net email account.</p><p>NHS England has developed a palliative and end of life care dashboard, which brings together all relevant local data in one place. The dashboard helps commissioners understand the palliative and end of life care needs of their local population, enabling integrated care boards (ICBs) to put plans in place to address and track the improvement of health inequalities, and ensure that funding is distributed fairly, based on prevalence.</p><p>As of April 2024, NHS England is including palliative and end of life care in the list of topics for regular performance discussions between national and regional leads. These meetings will provide an additional mechanism for supporting ICBs to continue improving palliative and end of life care for their local population.</p><p>The Ambitions Framework, refreshed by the National Palliative and End of Life Care Partnership, which is made up of NHS England and 34 partner organisations with experience of, and responsibility for, end of life care, sets out the vision to improve end of life care through partnership and collaborative action between organisations at local level throughout England, by setting out six key ambitions.</p><p>Furthermore, the National Institute for Health and Care Excellence (NICE) has published guidance and quality standards on end of life care for adults, and children and young people. These are based on best practice in developing and delivering care and, while not statutory, there is an expectation that commissioners and service providers take the guidelines into account when making decisions about how to best meet the needs of their local communities.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 26/04/2024 10:37:37 answering member 4527 label Biography information for Helen Whately
	tabling member	4471 label Biography information for Rachael Maskell

1713144

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Social Services: Digital Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to her Department's policy paper entitled People at the Heart of Care: adult social care reform white paper, published on 1 December 2021, whether the target for 80% of CQC registered social care providers to have a digital social care record in place by March 2024 was met.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	23166
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>We have increased the adoption of digital social care records (DSCRs) by Care Quality Commission (CQC) registered providers from 40% in December 2021, to at least 63% in February 2024. In January 2024, the Department updated this target to ensure that 80% of CQC registered providers and 80% of people who receive care will have a DSCR in place by March 2025. By extending timeframes, we can ensure that care providers who are yet to digitise have the time and support needed to successfully adopt DSCRs, and to reduce the risk of regional disparities in DSCR uptake. We’ve allocated a further £25 million this financial year, to ensure as many people as possible can benefit from a DSCR.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 29/04/2024 14:30:46 answering member 4527 label Biography information for Helen Whately
	tabling member	1506 label Biography information for Andrew Gwynne

1713145

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Palliative Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions she has had with (a) clinicians, (b) hospice leaders and (c) academics on future funding requirements for hospice and end of life care.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23232
	answer	answer is ministerial correction date of answer 26/04/2024 answer text <p>Integrated care boards (ICBs) are responsible for determining the level of locally available, National Health Service funded palliative and end of life care, including hospice care. ICBs are responsible for ensuring that the services they commission meet the needs of their local population.</p><p>The majority of palliative and end of life care is provided by NHS staff and services. However, we also recognise the vital part that voluntary sector organisations, including hospices, play in providing support to people at end of life, and their families. Most hospices are charitable, independent organisations which receive some statutory funding for providing NHS services. The amount of funding hospices receive is dependent on many factors, including what other statutory services are available within the ICB footprint. Charitable hospices provide a range of services which go beyond that which statutory services are legally required to provide. Consequently, the funding arrangements reflect this.</p><p>In July 2022, NHS England published statutory guidance and service specifications for commissioners on palliative and end of life care, setting out the considerations for ICBs to meet their legal duties, and making clear reference to the importance of access to services.</p><p>The Department and NHS England, alongside key partners, will continue to proactively engage with our stakeholders, including the voluntary sector and independent hospices, on an ongoing basis, in order to understand the issues they face, including that of future funding pressures. The Department is in ongoing discussions with NHS England, including its National Clinical Director, about the oversight and accountability of National Health Service palliative and end of life care commissioning.</p><p>From April 2024, NHS England will include palliative and end of life care in the list of topics for its regular performance discussions between national and regional leads. These national meetings will provide an additional mechanism for supporting ICBs in continuing to improve palliative and end of life care for their local population.</p><p>NHS England has commissioned the development of a palliative and end of life care dashboard, which brings together relevant local data in one place. The dashboard helps commissioners understand the palliative and end of life care needs of those in their local population, enabling ICBs to put plans in place to address and track the improvement of health inequalities. Additionally, the National Institute for Health and Care Research has established a new Policy Research Unit to build an evidence base on palliative and end of life care, with a specific focus on inequalities.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 23228 23229 question first answered 26/04/2024 09:56:37 answering member 4527 label Biography information for Helen Whately
	tabling member	4471 label Biography information for Rachael Maskell

1713146

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bereavement Counselling: Equality
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the geographical coverage of bereavement services; and whether she has identified (a) geographical, (b) socio-economic and (c) protected characteristic inequalities in the coverage of such services.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23233
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>No assessment has been made of the adequacy of geographical coverage of bereavement services, nor of the geographical, socioeconomic or protected characteristic inequalities in the coverage of such services. The Government wants people to be able to access the bereavement support they need, when they need it. We strongly encourage anyone struggling with bereavement, no matter how long after loss, to contact their general practitioner who can help provide support, signpost to specialist bereavement support charities, or make a referral to a counsellor.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 29/04/2024 16:27:07 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4471 label Biography information for Rachael Maskell

1713147

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the impact of childhood poverty on longitudinal health outcomes.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23234
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The Department delivers programmes to support the most vulnerable children and families, and reduce health inequalities. The Government published the Best Start for Life: A Vision for the 1,001 Critical Days, in March 2021. This sets out six action areas for improving support for families during the 1,001 critical days, to ensure every baby in England is given the best possible start in life, regardless of background.</p><p>The Government is investing an additional £300 million to improve support for families though the joint Department of Health and Social Care and Department for Education Family Hubs and Start for Life programme. It is implementing many elements of the Best Start for Life Vision, delivering a step change in outcomes for babies, children, and their parents and carers in 75 local authorities in England, including those with high levels of deprivation. The Government has commissioned two in-depth independent evaluations of the programme.</p><p>The Healthy Start scheme helps to encourage a healthy diet for pregnant women, babies, and young children aged under four years old from very low-income households. The latest Healthy Start data was published on 28 March 2024, with an uptake of 66%. Healthy Start now supports approximately 366,000 beneficiaries.</p><p>In November 2022, NHS England published Core20PLUS5, an approach to reducing health inequalities for children and young people at both a national and system level. The approach defines a target population cohort, and identifies five clinical areas requiring accelerated improvement, which are asthma, diabetes, epilepsy, oral health, and mental health. Where possible, indicators in the Child and Maternal Health Profile provide a breakdown by the index of multiple deprivation, which is available at the following link:</p><p><a href="https://fingertips.phe.org.uk/profile/child-health-profiles" target="_blank">https://fingertips.phe.org.uk/profile/child-health-profiles</a></p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 23235 23236 23237 question first answered 29/04/2024 13:57:00 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4471 label Biography information for Rachael Maskell

1713151

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how she is targeting health prevention services to support children who live in poverty.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23235
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The Department delivers programmes to support the most vulnerable children and families, and reduce health inequalities. The Government published the Best Start for Life: A Vision for the 1,001 Critical Days, in March 2021. This sets out six action areas for improving support for families during the 1,001 critical days, to ensure every baby in England is given the best possible start in life, regardless of background.</p><p>The Government is investing an additional £300 million to improve support for families though the joint Department of Health and Social Care and Department for Education Family Hubs and Start for Life programme. It is implementing many elements of the Best Start for Life Vision, delivering a step change in outcomes for babies, children, and their parents and carers in 75 local authorities in England, including those with high levels of deprivation. The Government has commissioned two in-depth independent evaluations of the programme.</p><p>The Healthy Start scheme helps to encourage a healthy diet for pregnant women, babies, and young children aged under four years old from very low-income households. The latest Healthy Start data was published on 28 March 2024, with an uptake of 66%. Healthy Start now supports approximately 366,000 beneficiaries.</p><p>In November 2022, NHS England published Core20PLUS5, an approach to reducing health inequalities for children and young people at both a national and system level. The approach defines a target population cohort, and identifies five clinical areas requiring accelerated improvement, which are asthma, diabetes, epilepsy, oral health, and mental health. Where possible, indicators in the Child and Maternal Health Profile provide a breakdown by the index of multiple deprivation, which is available at the following link:</p><p><a href="https://fingertips.phe.org.uk/profile/child-health-profiles" target="_blank">https://fingertips.phe.org.uk/profile/child-health-profiles</a></p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 23234 23236 23237 question first answered 29/04/2024 13:57:00 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4471 label Biography information for Rachael Maskell

1713154

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to tackle health inequality due to childhood poverty.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23236
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The Department delivers programmes to support the most vulnerable children and families, and reduce health inequalities. The Government published the Best Start for Life: A Vision for the 1,001 Critical Days, in March 2021. This sets out six action areas for improving support for families during the 1,001 critical days, to ensure every baby in England is given the best possible start in life, regardless of background.</p><p>The Government is investing an additional £300 million to improve support for families though the joint Department of Health and Social Care and Department for Education Family Hubs and Start for Life programme. It is implementing many elements of the Best Start for Life Vision, delivering a step change in outcomes for babies, children, and their parents and carers in 75 local authorities in England, including those with high levels of deprivation. The Government has commissioned two in-depth independent evaluations of the programme.</p><p>The Healthy Start scheme helps to encourage a healthy diet for pregnant women, babies, and young children aged under four years old from very low-income households. The latest Healthy Start data was published on 28 March 2024, with an uptake of 66%. Healthy Start now supports approximately 366,000 beneficiaries.</p><p>In November 2022, NHS England published Core20PLUS5, an approach to reducing health inequalities for children and young people at both a national and system level. The approach defines a target population cohort, and identifies five clinical areas requiring accelerated improvement, which are asthma, diabetes, epilepsy, oral health, and mental health. Where possible, indicators in the Child and Maternal Health Profile provide a breakdown by the index of multiple deprivation, which is available at the following link:</p><p><a href="https://fingertips.phe.org.uk/profile/child-health-profiles" target="_blank">https://fingertips.phe.org.uk/profile/child-health-profiles</a></p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 23234 23235 23237 question first answered 29/04/2024 13:57:00 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4471 label Biography information for Rachael Maskell

1713156

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of her policies on health outcomes for children who live in poverty.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23237
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The Department delivers programmes to support the most vulnerable children and families, and reduce health inequalities. The Government published the Best Start for Life: A Vision for the 1,001 Critical Days, in March 2021. This sets out six action areas for improving support for families during the 1,001 critical days, to ensure every baby in England is given the best possible start in life, regardless of background.</p><p>The Government is investing an additional £300 million to improve support for families though the joint Department of Health and Social Care and Department for Education Family Hubs and Start for Life programme. It is implementing many elements of the Best Start for Life Vision, delivering a step change in outcomes for babies, children, and their parents and carers in 75 local authorities in England, including those with high levels of deprivation. The Government has commissioned two in-depth independent evaluations of the programme.</p><p>The Healthy Start scheme helps to encourage a healthy diet for pregnant women, babies, and young children aged under four years old from very low-income households. The latest Healthy Start data was published on 28 March 2024, with an uptake of 66%. Healthy Start now supports approximately 366,000 beneficiaries.</p><p>In November 2022, NHS England published Core20PLUS5, an approach to reducing health inequalities for children and young people at both a national and system level. The approach defines a target population cohort, and identifies five clinical areas requiring accelerated improvement, which are asthma, diabetes, epilepsy, oral health, and mental health. Where possible, indicators in the Child and Maternal Health Profile provide a breakdown by the index of multiple deprivation, which is available at the following link:</p><p><a href="https://fingertips.phe.org.uk/profile/child-health-profiles" target="_blank">https://fingertips.phe.org.uk/profile/child-health-profiles</a></p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 23234 23235 23236 question first answered 29/04/2024 13:57:00 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4471 label Biography information for Rachael Maskell

1713158

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electronic Cigarettes and Smoking
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of harm reduction approaches for people using tobacco and vaping products to end their dependencies.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23239
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom, and causes around one in four cancer deaths in the UK. It also costs our country £17 billion a year, and puts a huge burden on the National Health Service. Smoking is an addiction and there is no liberty in addiction. It causes harm to not only to the smoker but to the whole of society. That is why we have introduced the Tobacco and Vapes Bill, to create the first smokefree generation and enable us to further crack down on youth vaping. In addition, we are investing an additional £70 million per year, over five years, to support local authority commissioned stop smoking services. The Tobacco and Vapes Bill is available at the following link:</p><p><a href="https://bills.parliament.uk/bills/3703." target="_blank">https://bills.parliament.uk/bills/3703.</a></p><p>Quitting smoking completely, immediately, and permanently is the best thing a smoker can do for their health, and smokers are three times as likely to succeed with stop smoking services (SSS) when compared to an unsupported quit attempt. The National Institute for Health and Care Excellence (NICE) has published recommendations on supporting people who do not want, or are not ready, to stop smoking in one go, to reduce the harm from smoking. The NICE’s guidance advises that the health benefits from reducing smoking are unclear, but if smokers reduce their smoking now, they are more likely to stop smoking in the future.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 29/04/2024 15:43:53 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4471 label Biography information for Rachael Maskell

1713159

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electronic Cigarettes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she is taking steps to (a) commission and (b) access scientific studies on the (i) physical and (ii) psychological impact of vaping (A) non nicotine and (B) nicotine products.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23240
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The health advice is clear, if you don’t smoke, don’t vape, and children should never vape. Vaping can play a role in helping adult smokers to quit, but the Government is concerned about the worrying rise in vaping among children, with youth vaping tripling in the last three years and one in five children having now used a vape.</p><p>Using the best available evidence is central to the development of regulations and requirements regarding vapes. This includes evidence on the health harms from vaping, both nicotine and non-nicotine vapes, in the short, medium, and long term. We monitor and assess the emerging international research, as can be seen in Public Health England’s Nicotine Vaping in England reports, and work closely with the academic and scientific community to interrogate the data on the physical and psychological effects of vaping and smoking.</p><p>We are also keen to ensure that we play an active role in driving forward the knowledge around longer-term health harms. As part of this, we are actively exploring options to partner with research bodies and commission research. We will provide more detail in due course.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 29/04/2024 15:45:09 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4471 label Biography information for Rachael Maskell

1713201

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicine: Higher Education
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress she has made on increasing the number of medical student places; and whether she expects to meet the commitment to double the number of medical school places by 2031.
	tabling member constituency	East Yorkshire
	tabling member printed	Sir Greg Knight
	uin	23143
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>We are on track to meeting the NHS Long Term Workforce Plan’s aim to double the number of medical school places in England, from 7,500 to 15,000 places a year by 2031/32. We have accelerated this expansion by allocating 205 additional medical school places for the 2024/25 academic year, and have provisionally allocated a further 350 additional places for the 2025/26 academic year. Final allocations will be published shortly. This will build on the expansion of medical school places in England to 7,500 per year, a 25% increase, that the Government completed in 2020, and which delivered five new medical schools.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 29/04/2024 15:16:26 answering member 4044 label Biography information for Andrew Stephenson previous answer version 30797 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
	tabling member	1200 label Biography information for Sir Greg Knight

1713205

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to help tackle the shortage of prescription medications for the treatment of diabetes.
	tabling member constituency	Birmingham, Hall Green
	tabling member printed	Tahir Ali
	uin	23302
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The Department has worked intensively with industry to seek commitments from them to address issues with the supply of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), used as a treatment for type 2 diabetes. As a result, deliveries have been expedited and supplies boosted, and the overall supply position in the United Kingdom has improved. Guidance for healthcare professionals, which was updated in March 2024 and supersedes the National Patient Safety Alert, now allows for the initiation of new patients onto Rybelsus tablets, an oral semaglutide, or Mounjaro KwikPen (tirzepatide), and provides advice on what to prescribe patients who are unable to obtain their existing GLP-1 RA treatment whilst there continue to be disruptions to the supply of some products.</p><p>We are aware of supply issues with some insulin products for the treatment of type 1 diabetes. However, the vast majority are in stock. Comprehensive management guidance on alternative products has been issued to the National Health Service where needed.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 29/04/2024 11:16:48 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4747 label Biography information for Tahir Ali